SANTA PAULA, Calif. — September 9, 2025 — Leads & Copy — Calavo Growers, Inc. (Nasdaq-GS: CVGW) reported its financial results for the third fiscal quarter and nine-month period ended July 31, 2025.
Total net sales were $178.8 million, a decrease of less than one percent from the prior year. Fresh segment sales were $155.9 million, a 5% decrease from the prior year. Prepared segment sales were $22.9 million, a 40% increase from the prior year.
Gross profit was $18.2 million, a 9% decrease from the prior year quarter, including approximately $4.2 million of discrete costs associated with a temporary Food and Drug Administration (“FDA”) detention hold on certain avocado imports from Mexico.
Net income from continuing operations attributable to Calavo Growers, Inc. was $4.7 million, or $0.26 per diluted share, compared to $5.4 million, or $0.30 per diluted share, in the prior year. Adjusted EBITDA was $15.1 million, compared to $12.9 million in the prior year.
For the nine-month period ended July 31, 2025, total net sales were $523.8 million, a 7% increase from the prior year period. Net income from continuing operations attributable to Calavo Growers, Inc. was $16.1 million, or $0.89 per diluted share, compared to $9.3 million, or $0.52 per diluted share, in the prior year period. Adjusted EBITDA was $35.7 million, compared to $29.9 million in the prior year period.
The Board of Directors declared a quarterly cash dividend of $0.20 per share to be paid on October 31, 2025 to shareholders of record on September 30, 2025.
On September 2, 2025, the U.S. Department of Justice officially notified the company that it has closed its FCPA inquiry related to its operations in Mexico.
Investor Contact:
Jeremy Apple
Senior Vice President
Financial Profiles, Inc.
calavo@finprofiles.com
310-622-8233
Source: Calavo Growers, Inc.
